Marimed (MRMD) Market Capitalization (2012 - 2026)

Marimed (MRMD) has reported Market Capitalization for 15 consecutive years, with $28.1 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Market Capitalization rose 2.34% year-over-year to $28.1 million in Q2 2026; TTM through Jun 2026 was $28.1 million, a 2.34% increase from a year earlier, with the FY2025 full-year figure at $35.7 million, down 21.97% from the prior year.
• Market Capitalization was $28.1 million for Q2 2026 at Marimed, up from $27.9 million in the prior quarter.
• Over five years, Market Capitalization peaked at $245.0 million in Q1 2022 and troughed at $27.4 million in Q2 2025.
• A 5-year average of $95.6 million and a median of $83.0 million in 2024 frame the typical range for Market Capitalization.
• Across the five-year window, Market Capitalization advanced 13.36% in 2023 and tumbled 64.17% in 2025, its largest moves.
• Over 5 years, Market Capitalization stood at $122.9 million in 2022, then slipped by 14.56% to $105.0 million in 2023, then slumped by 56.42% to $45.8 million in 2024, then fell by 21.97% to $35.7 million in 2025, then decreased by 21.39% to $28.1 million in 2026.
• The last three Market Capitalization figures came in at $28.1 million (Q2 2026), $27.9 million (Q1 2026), and $35.7 million (Q4 2025), per Business Quant data.